These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Relevance of high-dose chemotherapy in solid tumours. Nieboer P; de Vries EG; Mulder NH; van der Graaf WT Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050 [TBL] [Abstract][Full Text] [Related]
45. [Possibilities and indications of surgery for reduction of tumor volume or exeresis of metastases followed by chemotherapy and/or immunotherapy]. Mathe G; Garnier H; Kuss R; Binet JP; Le Brigand H; Genin J; Petit JY; Constans JP; Musset M; Schwarzenberg L; De Vassal F; Delgado M Chirurgie; 1976 May; 102(5):335-43. PubMed ID: 954531 [No Abstract] [Full Text] [Related]
46. [Transferability of animal experiment results to cytostatic chemotherapy on humans]. Karrer K Adv Clin Pharmacol; 1977; 14():89-97. PubMed ID: 596276 [No Abstract] [Full Text] [Related]
47. [Medical treatment of urothelial tumors of the bladder]. Ferrière JP; Dionet C; Dauplat J; Boiteux JP; Plagne R; Giraud B Ann Urol (Paris); 1988; 22(4):229-34. PubMed ID: 3056230 [TBL] [Abstract][Full Text] [Related]
48. [Adjuvant therapy of gastric cancer in the literature from 1980-1984]. Iwanaga T; Furukawa H Gan To Kagaku Ryoho; 1986 May; 13(5):1962-9. PubMed ID: 3085597 [TBL] [Abstract][Full Text] [Related]
49. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)]. Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376 [TBL] [Abstract][Full Text] [Related]
51. [Immunotherapy in radical surgery of colorectal carcinoma]. Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635 [TBL] [Abstract][Full Text] [Related]
52. Local cytostatic chemotherapy and immunotherapy. Klein E Geriatrics; 1968 May; 23(5):154-75. PubMed ID: 4869008 [No Abstract] [Full Text] [Related]
53. [Treatment of 37 surgical cancers with associated or isolated chemotherapy]. Montezin J Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093 [No Abstract] [Full Text] [Related]
54. Recent developments in chemotherapy of malignancy. Bertino JR Laryngoscope; 1975 Mar; 85(3):491-8. PubMed ID: 1091794 [No Abstract] [Full Text] [Related]
55. [Chemotherapy in the treatment of malignant tumors]. Greco T Osp Ital Chir; 1966 Jun; ():Suppl 8:1-104. PubMed ID: 5336484 [No Abstract] [Full Text] [Related]
56. [Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation]. Focan C Nouv Presse Med; 1975 Nov; 4(38):2709-12. PubMed ID: 1105421 [TBL] [Abstract][Full Text] [Related]
57. Outpatient continuous infusion of chemotherapy: a new direction in oncology. Butler WM; McElveen LJ; Baldwin PE J S C Med Assoc; 1986 Sep; 82(9):576-7. PubMed ID: 3464805 [No Abstract] [Full Text] [Related]
58. Metronomic chemotherapy: teaching old drugs new tricks? Vogelzang N Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217 [No Abstract] [Full Text] [Related]